Market Signal Briefing

NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bitdeer Technologies Group (NASDAQ: BTDR) between June 6, 2024 and November 10, 2025, both dates inclusive (the “Class Period”), of the important February 2, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Bitdeer securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Bitdeer class action, go to https://rosenlegal.com/submit-form/?case_id=49102 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 2, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants provided investors with material information concerning Bitdeer’s research and technology roadmap for its SEALMINER Bitcoin mining machine. Defendants’ statements included, among other things, confidence in Bitdeer’s mass production of its fourth-generation SEALMINER (A4) rigs using its SEAL04 ASIC (“application-specific integrated circuit”) chip technology expected to have a chip energy efficiency of as low as 5J/TH. Defendants provided these positive statements to investors while, at the same time, disseminating false and materially misleading statements and/or concerning material adverse facts concerning the true state of Bitdeer’s SEALMINER A4 project. Specifically, defendants failed to disclose that the SEAL04 chip projected to have a chip-level energy efficiency of 5 J/TH would be ready for use in the A4 rigs with an expected mass production to begin in the second quarter 2025. Such statements absent these material facts caused investors to purchase Bitdeer securities at artificially inflated prices. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Bitdeer class action, go to https://rosenlegal.com/submit-form/?case_id=49102 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
www.rosenlegal.com

Vancouver, British Columbia – January 16, 2026 – TheNewswire - Grafton Resources (CSE:GFT; OTCQB: PMSXF) ("Grafton Resources" or the "Company") is pleased to announce that the Company has entered into a non-binding letter of intent (the “LOI”) with Asesorias e Inversiones Sol SpA (the “Vendor”) pursuant to which the Company proposes to acquire a direct 100% interest in the Silver One project (“Silver One” or the “Project”) located in Chile (the “Proposed Acquisition”).

Highlights

Potentially high-grade silver-copper veins as waste dump vein material averages 296 g/t Ag and 2.6% Cu 

Historic mining district hosts many Au-Ag-Cu epithermal vein systems 

Silver One Project hosts an undrilled and open-ended mineralizing system 

Campbell Smyth, Chairman, commented: “Silver One offers the opportunity to explore a high-grade silver-copper target that is uniquely well suited for development. The project is located in a well-established mining area and Silver One has the potential to be the next high-grade Ag-Cu deposit in this district.

Grafton now has two ideally located projects in a premier mining jurisdiction. There is a global shortage of silver and copper assets with good grade, clean metallurgy and simple geometry. We plan to drill Silver One in the second half of 2026 and are currently building up our local exploration team. Silver One is also accessed from the same logistical hub as the recently signed Alicahue Copper project offering further logistical synergies.”

Merlin Marr-Johnson, Technical Advisor, commented: “Silver grades of almost 300 g/t in the waste material are highly encouraging. The hope is that the primary material is even higher grade. The high tenor of the target, coupled with good access means that significant value can be created within a compact package.”  

  Silver One Project Overview

Location

The Silver One Project is centered on the San Lorenzo 1-18 concession located in the historic Au-Ag-Cu mining Pedernal district of the Petorca Municipality, central Chile. The project is accessed via established gravel roads from Chincolco and Pedernales, with short private-road access to the site. Historic work was carried out by Eagle Rock Resources SpA (“Eagle Rock”) under a lease agreement with S.C.M. Cerro Pedernal Dos.

  Background

The Silver One Project is located in the region around Petorca which hosts nearly 90 ore bodies, mostly polymetallic veins, some copper veins, and one copper breccia pipe. The area is characterised by epithermal low sulfidation vein systems hosted by Cretaceous volcanic andesitic sequences (Camus et al., 1991) in the western foothills of the Andean Cordillera of central Chile.

The Silver One Project targets silver-copper-bearing sulphide vein systems historically exploited by underground methods. The adit mouth is located at 332,252 E; 6,448,714 N (WGS 84, UTM Zone 19 South) Historic workings indicate the presence of structurally controlled mineralization hosted within volcanic and volcaniclastic sequences, with mineral assemblages consistent with Ag–Cu sulphide systems typical of the region. Work completed by Eagle Rock focused on integrating modern survey techniques with geological mapping and targeted sampling:

High-resolution drone-based topographic survey, generating 2 m contour intervals and a 3D surface model. 

Surface geological mapping identifying a volcanic–volcaniclastic stratigraphic sequence dominated by andesitic lavas, volcanic breccias, and tuffs. 

Rehabilitation and LIDAR survey of the Esperanza Adit (~400 m), enabling accurate 3D modelling of underground access. 

Detailed underground geological mapping of the adit, identifying a vertically stacked sequence of grey to red andesites overlain by thick volcanic breccia and tuff units. 

Trenching and channel sampling of historic mine waste dumps to establish a proxy for grade where direct access to old stopes was not possible. 

Geological Interpretation and Results

The underground mapping identifies that mineralized veins are hosted within grey volcanic breccias with reducing characteristics, interpreted as the favourable horizon for Ag–Cu sulphide deposition. The absence of surface exposure implies mineralization is blind and structurally controlled, potentially confined to a coherent zone with a probable SW–NE structural orientation.

A detailed evaluation of a historic waste dump combined trenching, systematic sampling, granulometric analysis, topographic surveying, 3D modelling, and volumetric estimation. Ten pits (1–3 m deep) and 24 samples defined an estimated 8,120 tonnes of historic mine waste, with average grades of approximately 96 g/t Ag and 0.80% Cu, calculated using a loose bulk density of 1.43 g/cm³. The location of the waste dump and associated samples is 332,245 E; 6,448,707 N (WGS 84, UTM Zone 19 South).

The waste material was screened using a 5 cm mesh to obtain samples suitable for manual sorting. Vein material (silica–carbonate) was separated from host rock (andesite), and each fraction was sent to the laboratory for analysis as separate samples. The vein material showed sulphide mineralization dominated by tennantite–tetrahedrite (locally freibergite), chalcocite–covellite, chalcopyrite, galena, and rare bornite. The veins include abundant barite and banded quartz, consistent with epithermal to mesothermal vein systems. 13.85 kg of vein material was assayed at AAA Laboratories and returned an average grade of 296 g/t Ag and 2.6% Cu.

Project Potential & Next Steps

Although the historic workings are not fully accessible, the combination of underground geometry, favourable lithological hosts, and multi-element sulphide mineralization confirms the presence of an open-ended mineralizing system. Potential next steps include:

Securing safe access to historic stopes and raises to directly sample in situ vein material. 

Targeted geophysical surveys (IP/resistivity) to define sulphide structures beneath cover. 

Focused drilling to test continuity, thickness, and grade of interpreted vein zones. 

Transaction Terms

Under the terms of the LOI, the Company proposes to acquire the Project in exchange for total deemed consideration of C$820,000 comprised of:

(i) a cash payment of C$100,000 to the Vendor; and

(ii) the issuance of 800,000 common shares in the capital of the Company (the “Consideration Shares”) to the Vendor at a deemed price of $0.90 per Consideration Share having an aggregate deemed value of C$720,000. The shares issued will be subject to voluntary escrow provisions and will be released over 36 months.

The final structure of the Proposed Acquisition is subject to, among other things, the negotiation and execution of a definitive agreement, completion of satisfactory due diligence, and the satisfaction of customary closing conditions. There can be no assurance that a definitive agreement will be entered into or that the Proposed Acquisition will be completed.

The Proposed Acquisition is consistent with the Company’s strategy focused on the discovery and development of mineral assets in the Americas. Subject to closing, the Company intends to advance the Project through systematic technical review and disciplined exploration planning.

OTCQB Symbol Change

The Company is also pleased to announced that its common shares will commence trading under its new OTC ticker symbol “GFTFF", effective January 20, 2026.

The change from the previous symbol "PMSXF" to "GFTFF" is part of the Company's ongoing efforts to align its U.S. market identity with its current corporate name and Canadian Securities Exchange ticker "GFT." The Company's CUSIP number remain unchanged.

QA/QC Procedures

Eagle Rock followed robust QA/QC procedures. The aim was to characterise silver, copper, and associated metal content of historic waste dump material through systematic channel and rock sampling. Channel samples were cut using hand tools to a consistent width (~10–20 cm) and depth (~3–5 cm). Material was collected continuously along the channel and placed directly into labeled sample bags. The rock chips were screened to be greater than 5 cm and samples are intended to be indicative, not representative of bulk grade. The fragments were separated into vein, wall rock, and unmineralized host rock by hand, weighed by rock type, and samples were assigned a unique sample ID at the time of collection. The samples were sealed in heavy-duty plastic sample bags, tagged internally and externally, and transported by company personnel to the certified, independent AAA Laboratory in Chile. After standard sample preparation at the laboratory, silver and base metals were analysed using ICP-MS following four-acid digestion.

  Qualified Person

Gilberto Schubert (B.Sc., M.Sc., MBA, M.Sc. Min Ec.), a Qualified Person as defined by National Instrument 43-101 and an independent Technical Advisor to the Company, has reviewed and approved the technical information provided in this news release, including the sampling, analytical and test data underlying the technical information contained in this news release. Specifically, the QP verified selected laboratory assay certificates against the reported rock samples.

  About Grafton Resources

Grafton Resources is a Canadian exploration company listed on the Canadian Securities Exchange (CSE), focused on the discovery and development of mineral assets in the Americas. The Company is committed to responsible exploration, strong community partnerships, and generating shareholder value through disciplined project advancement.

On behalf of Grafton Resources.

Campbell Smyth
Interim Chief Executive Officer, Chairman and Director

For further information, please contact:

Campbell Smyth
[email protected]
+61403203402

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

This news release includes certain statements and information that constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts are forward-looking statements. Such forward-looking statements and forward-looking information specifically include, but are not limited to, statements that relate to the Proposed Acquisition, potential mineralization at the Project, future exploration plans on the Project and the timing and results of future exploration..

Statements contained in this release that are not historical facts are forward-looking statements that involve various risks and uncertainty affecting the business of the Company. Such statements can generally, but not always, be identified by words such as "expects", "plans", "anticipates", "intends", "estimates", "forecasts", "schedules", "prepares", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. All statements that describe the Company's plans relating to operations and potential strategic opportunities are forward-looking statements under applicable securities laws. These statements address future events and conditions and are reliant on assumptions made by the Company's management, and so involve inherent risks and uncertainties, as disclosed in the Company's periodic filings with Canadian securities regulators, including without limitation, risks related to the completion of the Proposed Acquisition; the dangers inherent in exploration, development and mining activities; actual exploration or development plans and costs differing materially from the Company’s estimates; the ability to obtain and maintain any necessary permits, consents or authorizations required for mining activities; environmental regulations or hazards and compliance with complex regulations associated with mining activities; climate change and climate change regulations; fluctuations in exchange rates; the availability of financing; operations in foreign and developing countries and the compliance with foreign laws, remote operations and the availability of adequate infrastructure; fluctuations in price and availability of energy and other inputs necessary for mining operations; shortages or cost increases in necessary equipment, supplies and labour; regulatory, political and country risks, including local instability or acts of terrorism and the effects thereof; the reliance upon contractors, third parties and joint venture partners; challenges to title or surface rights; the dependence on key personnel and the ability to attract and retain skilled personnel; the risk of an uninsurable or uninsured loss; adverse climate and weather conditions; litigation risk; and competition with other mining companies. As a result of these risks and uncertainties, and the assumptions underlying the forward-looking information, actual results could materially differ from those currently projected, and there is no representation by the Company that the actual results realized in the future will be the same in whole or in part as those presented herein. the Company disclaims any intent or obligation to update forward-looking statements or information except as required by law. Readers are referred to the additional information regarding the Company's business contained in the Company's reports filed with the securities regulatory authorities in Canada. Although the Company has attempted to identify important factors that could cause actual actions, events, or results to differ materially from those described in forward-looking statements, there may be other factors that could cause actions, events or results not to be as anticipated, estimated or intended. For more information on the Company and the risks and challenges of its business, investors should review the Company's filings that are available at www.sedarplus.ca.

The Company provides no assurance that forward-looking statements and information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements or information. Accordingly, readers should not place undue reliance on forward-looking statements or information. The Company does not undertake to update any forward looking statements, other than as required by law.

 

January 16, 2026 18:03 ET  | Source: VERSES AI Inc.

VANCOUVER, British Columbia, Jan. 16, 2026 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) ("VERSES'' or the "Company”), a cognitive computing company specializing in next-generation agentic software systems, today announces a refocused corporate strategy designed to concentrate resources on the Company’s core target markets and highest-priority initiatives.

In connection with this strategic focus, the Company has implemented a workforce restructuring that will reduce headcount by approximately half. The reduction includes the termination of certain previously furloughed employees and executives whose roles were not associated with core target market activities. In addition, certain executives are temporarily deferring their salaries. These actions demonstrate the leadership team's continued support for the Company and its business strategy and are expected to drastically reduce operating costs and improve the Company's liquidity position.

The Company is grateful for the contributions of all impacted employees and recognizes the dedication and effort they have brought to VERSES.

VERSES CEO Gabriel René said, “This Workforce restructuring will allow us to pursue our core target market with the greatest efficiency and speed and is a strategy that we believe positions us to drive the best return on investment and benefit to our shareholders.”

About VERSES

VERSES® is a cognitive computing company building next-generation intelligent agentic systems modeled after the wisdom and genius of Nature. Designed around first principles found in science, physics and biology, our flagship product, Genius,™ is an agentic enterprise intelligence platform designed to generate reliable domain-specific predictions and decisions under uncertainty. Imagine a Smarter World that elevates human potential through technology inspired by Nature. Learn more at verses.ai, LinkedIn and X.

On behalf of the Company
Gabriel René, Founder & CEO, VERSES AI Inc.
Press Inquiries: [email protected]

Investor Relations Inquiries 
James Christodoulou, Chief Financial Officer
[email protected], +1(212)970-8889

Cautionary Note Regarding Forward-Looking Statements

This news release contains statements which constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and plans of the Company. Forward-looking information and forward-looking statements are often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions. More particularly and without limitation, this news release contains forward–looking statements and information relating to the Company’s plan to concentrate resources on core target markets and highest-priority initiatives; the Company's workforce restructuring drastically reducing its operating costs and liquidity position; and the identified core target market providing the fastest speed to market, the greatest ability to capture market share, and the maximum return on investment.

The forward–looking statements and information are based on certain key expectations and assumptions made by the management of the Company. As a result, there can be no assurance that such plans will be completed as proposed or at all. Such forward-looking statements are based on a number of assumptions of management, including, without limitation, that the restructuring and related actions will deliver the anticipated operating cost reductions and improvements to liquidity position; the Company will maintain continuity of key operations, systems, vendor relationships and customer service levels during and after the restructuring; sufficient leadership and critical staff will be retained or recruited to execute the refocused strategy and serve the core target market; and demand within the identified core target market will materialize as expected, allowing faster speed to market, share capture and attractive returns on investment. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward–looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward–looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, loss of personnel, knowledge transfer gaps, systems changes or vendor transitions could impair service levels, delivery timelines or product quality; severance and other one-off charges may offset projected savings; inability to retain or hire critical leadership and technical personnel could impede strategy execution and customer support; demand in the identified core market may be weaker than expected; and other risks detailed from time to time in the filings made by the Company in accordance with securities regulations. Accordingly, readers should not place undue reliance on the forward–looking statements and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward–looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward–looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

Kitco News

The Leading News Source in Precious Metals

Kitco NEWS has a diverse team of journalists reporting on the economy, stock markets, commodities, cryptocurrencies, mining and metals with accuracy and objectivity. Our goal is to help people make informed market decisions through in-depth reporting, daily market roundups, interviews with prominent industry figures, comprehensive coverage (often exclusive) of important industry events and analyses of market-affecting developments.

Châtillon, France, January 16, 2026

DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing

The Company is sufficiently funded to support operations and commercial preparedness, including infrastructure buildup, to launch the VIASKIN® Peanut patch in children 4 to 7 years old in the U.S., if approved.

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market: DBVT) (the “Company”), a late-stage biopharmaceutical company, today announced a supplementary financing of €166.7 Million (the "Exercise") resulting from the full exercise of (i) 34,090,004 warrants attached to new ordinary shares issued by the Company on April 7, 2025 at an exercise price of €1.5939 (the "ABSA Warrants") resulting in the issuance of 59,657,507 new ordinary shares of the Company (the "New Shares") and (ii) 71,005,656 warrants issued by the Company on April 7, 2025 at an exercise price of €1.5764 (the "BS Warrants") resulting in the issuance of 71,005,656 pre-funded warrants (the "Second Pre-Funded Warrants"), allowing its holders to subscribe for an aggregate of up to 124,259,898 new shares.

Reminder of the main characteristics of the financing

The Company reminds that the financing consisted of the issuance through an offering reserved to categories of persons satisfying determined characteristics1 pursuant to the 24th resolution of the general meeting of shareholders of May 16, 2024, of:

34,090,004 new shares at a par value of €0.10 each with ABSA Warrants attached; and
71,005,656 units (the “PFW-BS-PFW”), each PFW-BS-PFW consisting of one pre-funded warrant to subscribe for one share of the Company (the "First Pre-Funded Warrants") and one BS Warrant to subscribe to one Second Pre-Funded Warrant. For further details on the financing, please refer to the press release published by the Company on March 27, 2025. 2

The terms of the financing provided that the ABSA Warrants and the BS Warrants were exercisable from their respective date of issue until the earlier of (i) April 7, 2027 and (ii) 30 days following the publication by the Company of a press release announcing that the ongoing VITESSE trial of the VIASKIN® Peanut patch in 4-7 years old met the primary endpoint defined in the VITESSE study protocol (the "VITESSE Topline Results").

Following the announcement of the positive VITESSE Topline Results on December 16, 20253, the ABSA Warrants and BS Warrants were exercisable until January 15, 2026.

As all ABSA Warrants and BS Warrants were exercised, no ABSA Warrant or BS Warrant remain outstanding.

The exercise of the ABSA Warrants resulted in the issuance of 59,657,507 New Shares.

The exercise of the BS Warrants resulted in the issuance of 71,005,656 Second Pre-Funded Warrants, which may give access to a maximum of 124,259,898 new ordinary shares of the Company (the "Second PFW Shares") if all Second Pre-Funded Warrants are exercised.

It is reminded that the exercise of one Second Pre-Funded Warrant will give the right to subscribe to one point seventy five (1.75) new ordinary share of the Company, at an aggregate price of €1.5939 per Second Pre-Funded Warrant, it being specified that as the exercise price has been prefunded on the date of issue of the Second Pre-Funded Warrants up to €1.5764, only the balance (corresponding to an amount equal to €0.0175 per Second Pre-Funded Warrant) will have to be paid upon the date on which the Second Pre-Funded Warrants are exercised.

In addition, as of today, it is reminded that 35,153,512 First Pre-Funded Warrants and 67 924 456 Second Pre-Funded Warrants are outstanding and may give access to a total of 154,021,310 new ordinary shares if all the outstanding Pre-Funded Warrants are exercised.

The Company reminds that the financing was not subject to a prospectus requiring an approval of the French Financial Markets Authority (Autorité des Marchés Financiers) (the “AMF”). In accordance with Article 1(5) (ba) of the Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017, as amended (the “Prospectus Regulation”), the Company has filed with the AMF a document containing the information set out in Appendix IX of the Prospectus Regulation, copies of which are available free of charge on the Company’s website (www.dbv-technologies.com).

Use of Proceeds
The aggregate gross proceeds from the Exercise are €166.7 million. If all of the outstanding First Pre-Funded Warrants and Second Pre-Funded Warrants are exercised, the aggregate gross proceeds are estimated to be approximately €168.2 million, allowing for a total financing of €284.5 million (as indicated in the press release published by the Company on March 27, 2025).

The proceeds from the Exercise, together with existing cash and cash equivalents, will be mainly used (i) for working capital and general corporate purposes, (ii) to finance the preparation and submission of a potential Biologics License Application (BLA) and (iii) to finance the launch of VIASKIN® Peanut for children aged 4-7 years in the U.S., if approved.

Working Capital Statement

Based on its current operations, plans and assumptions, the Company estimates that its existing cash and cash equivalents, including the proceeds from the Exercise, should enable the Company to finance its operations for at least the next 12 months, including through the anticipated launch of the VIASKIN® Peanut patch for children aged 4 to 7 years old in the U.S., if approved, and that, as of the date of this press release, there is no substantial doubt about the Company's ability to continue as a going concern.

These estimates are based on the Company’s current business plan and excludes any additional expenditures related to other programs than the VIASKIN® Peanut or resulting from the potential in licensing or acquisition of additional product candidates or technologies, or any associated development the Company may pursue. The Company may have based these estimates on assumptions that are incorrect, and the Company may end up using its resources sooner than anticipated.

Admission to Trading of the New Shares

The Company's shares are all of the same class, with a par value of €0.10. The New Shares will be admitted to trading on Euronext Paris (compartment B), on the same listing line as the existing shares, under the same ISIN code FR0010417345 and the symbol “DBV”.

Impact of the Issue of the New Shares on Shareholders’ Equity and on the Share Capital

On an indicative basis, the impact of the issue of the New Shares on (i) the share of the Company’s consolidated shareholder’s equity per share and (ii) the ownership interest of a shareholder holding 1.00% of the Company’s share capital prior to the issue of the New Shares (calculation based on shareholders’ equity on September 30, 2025) and the number of the Company’s shares as of the date of this press release (exclusive of treasury shares) is as follows: 

 Ownership interest (in %)Share of equity per share (in euros) On a non-diluted basisOn a diluted basis(1)On a non-diluted basisOn a diluted basis(1)Prior to the issue of 59,657,507 New Shares1,00%0,53%0,220,63Following the issue of 59,657,507 New Shares0,78%0,46%0,370,67 (1) The calculations are based on the assumption of the exercise of all the warrants, free shares and stock options outstanding as of the date of this press release, giving access to a maximum of 456,494,439 shares.

Evolution of the Shareholding Structure in Connection with the Issue of the New Shares
To the Company’s best knowledge, the shareholding structure of the Company before the issue of the New Shares:

ShareholdersShareholders (non-diluted)Shareholders (diluted)Number of shares and voting rights% of share capital and voting rights*Number of shares and voting rights% of share capital and voting rights*Baker Brothers Investments23 468 16311.08%111 672 95824.46%Suvretta17 910 2218.45%56 822 96412.45%Artisan Partners, L.P.16 788 0007.92%16 788 0003.68%Invus15 349 0007.24%15 349 0003.36%Bpifrance Participations S.A.10 898 6005.14%17 455 3813.82%Shares held by the Company*58 7010.03%58 7010.01%Management(1)160 7040.08%9 774 5122.14%Others127 245 96960.06%228 572 92350.07%Total211 879 358100.00%456 494 439100.00% *Given the low percentage of treasury shares without voting rights, there is no significant difference between the theoretical percentage of voting rights and the actual percentage of voting rights.
(1) Shares held by the members of the Executive Committee.

To the Company’s best knowledge, the shareholding structure of the Company following the issue of the New Shares:

ShareholdersShareholders (non-diluted)Shareholders (diluted)Number of shares and voting rights% of share capital and voting rights*Number of shares and voting rights% of share capital and voting rights*Baker Brothers Investments23 468 1638.64%111 672 95824.46%Janus Henderson20 469 3927.54%34 115 3437.47%Suvretta18 524 7006.82%57 437 44312.58%Artisan Partners, L.P.16 788 0006.18%16 788 0003.68%Invus15 349 0005.65%15 349 0003.36%Adage14 189 0955.23%22 872 8825.01%MPM14 331 0595.28%32 021 4247.01%Shares held by the Company*58 7010.02%58 7010.01%Management(1)160 7040.06%9 774 5122.14%Others148 198 05154.58%156 404 17634.26%Total 271 536 865100.00%456 494 439100.00% * Given the low percentage of treasury shares without voting rights, there is no significant difference between the theoretical percentage of voting rights and the actual percentage of voting rights.
(1) Shares held by the members of the Executive Committee.

About DBV Technologies

DBV Technologies is a late-stage biopharmaceutical company developing treatment options for food allergies and other immunologic conditions with significant unmet medical need. DBV Technologies is currently focused on investigating the use of its proprietary VIASKIN® patch technology to address food allergies, which are caused by a hypersensitive immune reaction and characterized by a range of symptoms varying in severity from mild to life-threatening anaphylaxis. Millions of people live with food allergies, including young children. Through epicutaneous immunotherapy (EPIT), the VIASKIN® patch is designed to introduce microgram amounts of a biologically active compound to the immune system through intact skin. EPIT is a new class of non-invasive treatment that seeks to modify an individual’s underlying allergy by re-educating the immune system to become desensitized to allergen by leveraging the skin’s immune tolerizing properties. DBV Technologies is committed to transforming the care of food allergic people. The Company’s food allergy programs include ongoing clinical trials of VIASKIN Peanut in peanut allergic toddlers (1 through 3 years of age) and children (4 through 7 years of age).

DBV Technologies is headquartered in Châtillon, France, with North American operations in Warren, NJ. The Company’s ordinary shares are traded on segment B of Euronext Paris (DBV, ISIN code: FR0010417345) and the Company’s ADSs (each representing five ordinary shares) are traded on the Nasdaq Capital Market (DBVT – CUSIP: 23306J309).

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, included in this press release are forward-looking statements. These statements include, but are not limited to, statements about the Company’s financial condition, forecast of its cash runway, and financing plans, the potential exercise by investors of the First Pre-Funded Warrants and the Second Pre-Funded Warrants, the Company’s business strategy and goals, forecasts and estimates with respect to the Company’s planned and ongoing clinical trials, including the design, duration, timing, and costs for those trials, and the results and timing thereof and regulatory matters with respect thereto, clinical trial data releases and publications, the information, insights and impacts that may be gathered from clinical trials, the potential regulatory submissions, regulatory approval, launch and commercialization of the Company’s product candidates. These forward-looking statements and estimates are not promises or guarantees and involve substantial risks and uncertainties. At this stage, the Company’s product candidates have not been authorized for sale in any country. Among the factors that could cause actual results to differ materially from those described or projected herein include the Company’s ability to obtain necessary financing, uncertainties associated generally with research and development, clinical trials and related regulatory reviews and approvals, and the Company’s ability to successfully execute on its budget discipline measures. A further list and description of risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements in this press release can be found in the Company’s regulatory filings with the AMF, the Company’s filings and reports with the U.S. Securities and Exchange Commission (“SEC”), including in future filings and reports made with the AMF and SEC by the Company. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements and estimates, which speak only as of the date hereof. Other than as required by applicable law, the Company undertakes no obligation to update or revise the information contained in this press release.

The Company reminds that the going concern assessment is made as of the date of this press release based on management’s current assumptions. In accordance with U.S. GAAP, IFRS, SEC and AMF rules, the Company will update its going‑concern evaluation as of the issuance of its Annual Report on Form 10‑K and the universal registration document.

VIASKIN is a registered trademark of DBV Technologies.

Investor Relations Contact
Jonathan Neely
DBV Technologies
[email protected]

Media Contact
Brett Whelan
DBV Technologies
[email protected]

1 (i) natural person or legal entity, including company, trust, investment fund or other investment vehicle, regardless of their form, under French or foreign law, investing on a regular basis in the pharmaceutical, biotechnological or medical technology sector, and/or (ii) French or foreign company, institutions or entities of any form, carrying out a significant portion of its business in the pharmaceutical, chemical, medical devices or technology sectors or conducting research in these areas; and/or (iii) French or foreign investment service provider, or any foreign establishment with equivalent status, likely to guarantee the completion of an issue intended to be placed with the persons referred to in (i) and/or (ii) above or in connection with the implementation of an equity or bond financing line and, in this context, to subscribe for the securities issued.
2https://dbv-technologies.com/press_releases/dbv-technologies-announces-financing-of-up-to-306-9-million-e284-5-million-to-advance-viaskin-peanut-patch-through-biologics-license-application-submission-and-u-s-commercial-launch-if-appr/
3 https://dbv-technologies.com/press_releases/dbv-technologies-announces-positive-topline-results-from-phase-3-vitesse-trial-of-viaskin-peanut-patch-in-peanut-allergic-children-aged-4-7-years/

PDF Version

As earnings season continues, CNBC's Jim Cramer on Friday walked investors through next week on Wall Street, highlighting quarterly reports from companies including Netflix, Intel, Capital One Financial and McCormick.

"It's an awfully odd week, this second week of earnings season, as light as the next week is heavy," Cramer said. "Except for a couple of cases, I think it's best to keep your bat on your shoulder and hope for a better set of pitches."

Tuesday brings earnings from homebuilder D.R. Horton, 3M, Netflix and United Airlines. So far during earnings season, homebuilders have disappointed, Cramer said. But he added that he's starting to see "green shoots" in the housing sector. Conglomerate 3M has been "quietly surprising people this year," Cramer said, and he likes the stock ahead of the quarter. He said he's waiting to hear what Netflix has to say about why it needs to acquire Warner Bros. Discovery, as well as why it's willing to pay billions for the company. Cramer also recommended buying United ahead of the quarter, indicating that the post-Covid travel theme is still relevant.

On Wednesday, Johnson & Johnson and Charles Schwab will report, and Cramer said these two stocks are "hard to keep down." Cramer praised Johnson & Johnson's moves to become primarily a pharmaceutical company. He conceded that the outfit is still dealing with lawsuits related to its talc products, but suggested that they don't have a huge impact on the stock. Cramer said Schwab has become a "repository of a big chunk of the gigantic pool of money" from older generations as they transfer wealth to younger generations.

Thursday brings the PCE price index, a key inflation matric, and Cramer said he thinks it will show "a restrained set of numbers." Procter & Gamble, GE Aerospace and Freeport-McMoRan will also report that day. Cramer said he doesn't expect an amazing quarter from Procter & Gamble, but said he likes the company's brands and new CEO. He also praised GE Aerospace, saying he expects the outfit to report a great quarter due to the huge plane backlog. Copper and gold have been "red hot," Cramer said, so he thinks it's likely Freeport-McMoRan will "will get its fair share of money coming in."

Intel, Capital One, Intuitive Surgical and McCormick are also set to post earnings on Thursday. Intel stock has been performing well since CEO Lip Bu Tan took the reigns last year, Cramer suggested. But Intel's earnings might not be big enough given the competitive nature of the semiconductor space, he continued, adding that the stock needs a rest after its huge run. Cramer said he hopes Capital One will detail its acquisition of credit card name Discovery as well as its large buyback. Cramer suggested Intuitive Surgical's report could be the "lone surprise blowout" of the week. Food stocks have struggled recently, he continued. While Cramer likes McCormick, he expressed uncertainty about the quarter.

On Friday, SLB will release its quarterly report. Cramer said he thinks it will be difficult for SLB to deliver great numbers given the low price of crude.

Sign up now for the CNBC Investing Club to follow Jim Cramer's every move in the market.

Disclaimer The CNBC Investing Club holds shares of Capital One and Procter & Gamble.

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram

Questions, comments, suggestions for the "Mad Money" website? [email protected]

Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - Eric Sprott announces that today, 2176423 Ontario Ltd., a corporation which is beneficially owned by him, purchased 600,500 common shares (Shares) of Max Power Mining Corp. over the Canadian Securities Exchange (representing approximately 0.5% of the outstanding shares on non-diluted basis) at a price of $0.8205 per share for aggregate consideration of $492,710.25.

Prior to the acquisition of Shares, Mr. Sprott beneficially owned 10,369,318 Shares and 10,369,318 Share purchase warrants (Warrants), representing approximately 9.3% of the outstanding Shares on a non-diluted basis and 17.0% of the outstanding Shares on a partially-diluted basis assuming exercise of such Warrants. Mr. Sprott now beneficially owns and controls 10,969,818 Shares and 10,369,318 Warrants, representing approximately 9.8% of the outstanding Shares on a non-diluted basis and 17.5% of the outstanding Shares on a partially-diluted basis assuming exercise of such Warrants. The acquisition resulted in a decrease in holdings, on a partially diluted basis, of approximately 6.0% since the date of the last filing of an early warning report.

The Shares were acquired for investment purposes. Mr. Sprott has a long-term view of the investment and may acquire additional securities including on the open market or through private acquisitions or sell the securities including on the open market or through private dispositions in the future depending on market conditions, reformulation of plans and/or other relevant factors.

Max Power is located at 15 Innovation Boulevard, Saskatoon, Saskatchewan, S7N 2X8. A copy of the early warning report with respect to the foregoing will appear on Max Power's profile on SEDAR+ at www.sedarplus.ca and may also be obtained by calling Mr. Sprott's office at (416) 945-3294 (2176423 Ontario Ltd., 7 King Street East, Suite 1106, Toronto, Ontario, M5C 3C5).

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/280719

Source: Eric Sprott

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Blue Owl Capital Inc. (NYSE: OWL) between February 6, 2025 and November 16, 2025, inclusive (the “Class Period”), of the important February 2, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Blue Owl securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Blue Owl class action, go to https://rosenlegal.com/submit-form/?case_id=48876 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 2, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Blue Owl was experiencing a meaningful pressure on its asset base from business development companies (“BDC”) redemptions; (2) as a result, Blue Owl was facing undisclosed liquidity issues; (3) as a result, Blue Owl would be likely to limit or halt redemptions of certain BDCs; and (4) accordingly, defendants had downplayed the true scope and severity of the negative impact as a result of the foregoing, defendants’ positive statements about Blue Owl’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Blue Owl class action, go to https://rosenlegal.com/submit-form/?case_id=48876 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced that its Shareholders (as defined below) have approved the acquisition of all of the issued and outstanding common shares of the Company (the “Common Shares” and the holders of the Common Shares, the “Shareholders”) by XenoTherapeutics, Inc. and Xeno Acquisition Corp. (jointly “Xeno”) a non-profit biotechnology company, by way of a statutory plan of arrangement (the “Transaction” or the “Arrangement”) at the special meeting of Shareholders held today (the “Meeting”).

The special resolution approving the Arrangement was approved by: (i) 99.76% of the votes cast by Shareholders present in person or represented by proxy at the Meeting, and (ii) 99.76% of the votes cast by Shareholders, present in person or represented by proxy at the Meeting, excluding for this purpose the votes required to be excluded pursuant to Multilateral Instrument 61- 101 Protection of Minority Security Holders in Special Transactions.

At the Meeting, Shareholders also approved: (a) on an advisory and non-binding basis, the compensation to be paid or become payable to the Company’s named executive officers that is based on or otherwise relates to the Arrangement by 99.34% of the votes cast by Shareholders present in person or represented by proxy at the Meeting; and (b) in the event the Arrangement is terminated, (i) the voluntary liquidation and dissolution of the Company by 99.75% of the votes cast by Shareholders present in person or represented by proxy at the Meeting and (ii) the appointment of KPMG LLP or, in the alternative, another liquidator of nationally recognized experience, as the liquidator of the Company with authorization for the board of directors of the Company to set the remuneration of the liquidator by 99.75% of the votes cast by Shareholders present in person or represented by proxy at the Meeting.

The Arrangement is subject to the approval of the Superior Court of Québec (the “Court”) and other customary closing conditions. The Court hearing for the final order to approve the Arrangement is expected to take place on January 23, 2026 and, assuming receipt of the approval of the Court and satisfaction of other customary conditions to closing, the completion of the Arrangement is expected to occur on or about January 28, 2026.

About Repare Therapeutics Inc.

Repare Therapeutics is a clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. Repare Therapeutics has developed highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company’s clinical-stage pipeline includes RP-3467, a Phase 1 Polθ ATPase inhibitor; and RP-1664, a Phase 1 PLK4 inhibitor. For more information, please visit www.reparerx.com and follow @Reparerx on X (formerly Twitter) and LinkedIn.

About XenoTherapeutics, Inc.

XenoTherapeutics, Inc. is a Massachusetts-based 501(c)(3) research foundation focused on advancing xenotransplantation through scientific research, clinical development, and public education. For more information, please visit www.xenotx.org.

Forward Looking Statements

This news release contains certain information which, as presented, constitutes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of applicable securities laws in Canada. All statements in this news release other than statements of historical facts are forward-looking statements and forward-looking information. These statements may be identified by words such as “aims,” “anticipates,” “believes,” “could,” “estimates,” “expects,” “forecasts,” “goal,” “intends,” “may,” “plans,” “possible,” “potential,” “seeks,” “will” and variations of these words or similar expressions that are intended to identify forward-looking statements, although not all forward-looking statements contain these words. Forward-looking statements in this news release include, but are not limited to, statements regarding: the proposed timing and completion of the Transaction; the timing and receipt of Court approval of the Transaction; the satisfaction of the conditions to the completion of the Transaction; and any other statements that are not statements of historical fact. These forward-looking statements are based on the Company’s expectations and assumptions as of the date of this news release. Each of these forward-looking statements involves risks and uncertainties, many of which are outside of the control of Repare, that could cause the Company’s actual results to differ materially from those expressed or implied by the forward-looking statements, including the consummation of the Transaction and the anticipated benefits thereof. Many factors may cause differences between current expectations and actual results, including, but not limited to those related to: (i) the completion of the Transaction on anticipated terms and timing, including obtaining required Court approvals, and the satisfaction of other conditions to the completion of the Transaction; (ii) potential litigation relating to the Transaction that could be instituted by or against the Company, Xeno, XOMA Royalty Corporation or their respective directors or officers, including the effects of any outcomes related thereto; (iii) the risk that disruptions from the Transaction will harm the Company’s business, including current plans and operations; (iv) the ability of the Company to retain and hire key personnel; (v) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the Transaction; (vi) continued availability of capital and financing and rating agency actions; (vii) legislative, regulatory and economic developments affecting the Company’s business; (viii) the accuracy of the Company’s financial projections; (ix) general business, market and economic conditions; (x) certain restrictions during the pendency of the Transaction that may impact the Company’s ability to pursue certain business opportunities or strategic transactions; (xi) unpredictability and severity of catastrophic events, including but not limited to acts of terrorism, pandemics, outbreaks of war or hostilities, as well as the Company’s response to any of the aforementioned factors; (xii) significant transaction costs associated with the Transaction; (xiii) the possibility that the Transaction may be more expensive to complete than anticipated, including as a result of unexpected factors or events; (xiv) competitive responses to the Transaction; and (xv) the risks and uncertainties that are described in the Company’s definitive proxy statement on Schedule 14A in respect of the Transaction (the “Proxy Statement”), which is available on the Company’s EDGAR and SEDAR+ profiles and as otherwise disclosed from time to time on the Company’s EDGAR and SEDAR+ profiles. While the list of factors presented here and in the Proxy Statement is considered representative, no such list should be considered a complete statement of all potential risks and uncertainties related to the Transaction.

Other factors that may cause the Company’s actual results to differ from those expressed or implied in the forward-looking statements in this news release are identified in the section titled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the U.S. Securities and Exchange Commission (the “SEC”) and the Autorité des Marchés Financiers (Quebec) (“AMF”) on March 3, 2025, and in other filings made with the SEC and AMF from time to time, including the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2025. The Company expressly disclaims any obligation to update any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise, except as otherwise required by law. For more information, please visit reparerx.com and follow Repare on X (formerly Twitter) at @RepareRx and on LinkedIn at https://www.linkedin.com/company/repare-therapeutics/.

More News From Repare Therapeutics Inc.

MONTREAL--(BUSINESS WIRE)--TOMAGOLD CORPORATION (TSXV: LOT; OTCPK: TOGOF) (“TomaGold” or the “Company”) has entered into an advertising and investor awareness campaign with Dig Media Inc. dba Investing News Network (INN). INN is a private company headquartered in Vancouver, Canada, dedicated to providing independent news and education to investors since 2007. For the 12-month term of the agreement, INN will provide advertising to increase awareness of TomaGold. INN does not provide Investor Rel.

January 16, 2026 17:00 ET  | Source: DPM Metals Inc.

TORONTO, Jan. 16, 2026 (GLOBE NEWSWIRE) -- DPM Metals Inc. (TSX: DPM, ASX: DPM) (ARBN: 689370894) (“DPM” or “the Company”) announced that the Company has filed a technical report for its Dumitru Potok, Rakita North and Frasen prospects in Serbia (the “Report”). The purpose of the Report is to support the Inferred Mineral Resource estimate for the Dumitru Potok, Rakita North and Frasen prospects, as previously disclosed in the Company’s news release dated December 2, 2025.

The Report has been prepared pursuant to the Canadian Securities Administrator’s National Instrument 43-101 – Standards of Disclosure for Mineral Projects. The Report and the December 2, 2025 news release are both available for review on SEDAR+ (www.sedarplus.ca) and on the Company’s website (www.dpmmetals.com). Readers are encouraged to refer to the risks, assumptions and key parameters identified in the Report for additional information.

About DPM Metals Inc.

DPM Metals Inc. is a Canadian-based international gold mining company with operations and projects located in Bulgaria, Bosnia and Herzegovina, Serbia and Ecuador. Our strategic objective is to become a mid-tier precious metals company, which is based on sustainable, responsible and efficient gold production from our portfolio, the development of quality assets, and maintaining a strong financial position to support growth in mineral reserves and production through disciplined strategic transactions. This strategy creates a platform for robust growth to deliver above-average returns for our shareholders. DPM trades on the Toronto Stock Exchange (symbol: DPM) and the Australian Securities Exchange as a Foreign Exempt Listing (symbol: DPM).

For further information please contact:

Jennifer Cameron
Director, Investor Relations
Tel: (416) 219-6177
[email protected]

Cautionary Note Regarding Forward-Looking Statements

This news release contains “forward looking statements” or “forward looking information” (collectively, “Forward Looking Statements”) that involve a number of risks and uncertainties. Forward Looking Statements are statements that are not historical facts and are generally, but not always, identified by the use of forward looking terminology such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “outlook”, “intends”, “anticipates”, “believes”, or variations of such words and phrases or that state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved, or the negative of any of these terms or similar expressions. The Forward Looking Statements in this news release relate to, among other things, the Company’s strategic objectives. Forward Looking Statements are based on certain key assumptions and the opinions and estimates of management, as of the date such statements are made, and they involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of DPM to be materially different from any other future results, performance or achievements expressed or implied by the Forward Looking Statements. Such factors include, among others, those risk factors discussed or referred to in the documents (including without limitation DPM’s most recent Annual Information Form) filed from time to time with the securities regulatory authorities in all provinces and territories of Canada and available on SEDAR+ at www.sedarplus.ca. The reader has been cautioned that the foregoing list is not exhaustive of all factors which may have been used. Although DPM has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in Forward Looking Statements, there may be other factors that cause actions, events or results not to be anticipated, estimated or intended. There can be no assurance that Forward Looking Statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. DPM’s Forward Looking Statements reflect current expectations regarding future events and speak only as of the date hereof. Unless required by securities laws, DPM undertakes no obligation to update Forward Looking Statements if circumstances or management’s estimates or opinions should change. Accordingly, readers are cautioned not to place undue reliance on Forward Looking Statements.

Cautionary Note Regarding Mineral Exploration Results

DPM is not required to report on minerals exploration results, mineral resources and ore reserves in accordance with Chapter 5 of the ASX Listing Rules or the JORC Code 2012 due to DPM’s Foreign Exempt Listing on the ASX. DPM’s mineral reserves and mineral resources are prepared in accordance with NI 43-101 and the Canadian Institute of Mining, Metallurgy and Petroleum—Definition Standards adopted by the CIM Council on 10 May 2014, as required by Canadian securities regulatory authorities, which may differ from the requirements of the ASX Listing Rules and the JORC Code 2012.

-

WINONA, Minn.--(BUSINESS WIRE)--Fastenal Company (Nasdaq:FAST) ('Fastenal,' 'we,' 'our,' or 'us') reported its board of directors declared a dividend of $0.24 per share to be paid in cash on February 26, 2026 to shareholders of record at the close of business on January 29, 2026. Except for share and per share information, dollar amounts are stated in millions.

We began paying annual dividends in 1991, semi-annual dividends in 2003, and then expanded to quarterly dividends in 2011. In addition to these regular dividend payments, we have previously paid special one-time dividends in December 2008, December 2012, December 2020, and December 2023. Our board of directors currently intends to continue paying quarterly dividends, though all future determinations as to payment of dividends will depend upon the financial condition and results of operations of Fastenal and such other factors as are deemed relevant by the board of directors at that time.

In 2026, 2025, and 2024, we paid (or declared) dividends as follows:

Year

First

Quarter

Second

Quarter

Third

Quarter

Fourth

Quarter

Total

2026

$

0.240

2025

$

0.215

$

0.220

$

0.220

$

0.220

$

0.875

2024

$

0.195

$

0.195

$

0.195

$

0.195

$

0.780

Dividend and common stock repurchase activity during the last ten years is as follows:

Average Per

Total

Dividends per Share

Total Value of

Total Number

Share Price of

Dividend

Dividends

Regular

Special

Total

Common Stock

of Shares

Common Stock

Year

Payments

Paid

Dividend

Dividend

Dividend

Purchased

Purchased

Purchased

2026

One (1)

$

275.5

$

0.240

$

—

$

0.240

$

—

—

$

—

2025

Four

$

1,004.2

$

0.875

$

—

$

0.875

$

—

—

$

—

2024

Four

$

893.3

$

0.780

$

—

$

0.780

$

—

—

$

—

2023

Five (2)

$

1,016.8

$

0.700

$

0.190

$

0.890

$

—

—

$

—

2022

Four

$

711.3

$

0.620

$

—

$

0.620

$

237.8

10,000,000

$

23.79

2021

Four

$

643.7

$

0.560

$

—

$

0.560

$

—

—

$

—

2020

Five (2)

$

803.4

$

0.500

$

0.200

$

0.700

$

52.0

3,200,000

$

16.27

2019

Four

$

498.6

$

0.435

$

—

$

0.435

$

—

—

$

—

2018

Four

$

441.9

$

0.385

$

—

$

0.385

$

103.0

8,000,000

$

12.88

2017

Four

$

369.1

$

0.320

$

—

$

0.320

$

82.6

7,600,000

$

10.86

Ten Year Total

$

6,657.8

$

5.415

$

0.390

$

5.805

$

475.4

28,800,000

$

16.51

In the fourth quarter of 2025, we did not repurchase any shares of our common stock.

We have authority to purchase up to 12,400,000 shares of our common stock under the July 12, 2022 authorization. This authorization does not have an expiration date.

All share and per share information reflects the two-for-one stock split in each of 2019 and 2025.

About Fastenal

With approximately 1,600 branch locations spanning 25 countries, Fastenal's 24,000 employees supply a broad range of fasteners, safety products, metal cutting products, and other industrial supplies to customers engaged in manufacturing, construction, warehouse and storage, data centers, wholesale, and federal, state, and local government. By investing in local experts and inventory, customer-facing technology, wide-ranging services, and best-in-class sourcing and logistics, we offer a unique combination of capabilities to help our customers reduce cost, risk, and scalability constraints in their global supply chains. This "high-touch, high-tech" approach is reflected in our tagline, Where Industry Meets Innovation™.

Additional information regarding Fastenal is available on our website at www.fastenal.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains statements that are not historical in nature and that are intended to be, and are hereby identified as, "forward looking statements" as defined in the Private Securities Litigation Reform Act of 1995, including statements regarding expectations as to payment of a quarterly cash dividend and stock repurchase activity in the foreseeable future. Any future determination as to payment of dividends or stock repurchases will depend upon the financial condition and results of operations of Fastenal and such other factors as are deemed relevant by the board of directors. For example, a change in business needs including working capital and funding for acquisitions, or a change in income tax law relating to dividends or stock repurchases, could cause us to decide not to pay a dividend in the future or not to repurchase common stock pursuant to the existing share repurchase authorization. A discussion of other risks and uncertainties is included in our filings with the Securities and Exchange Commission, including our most recent annual report and subsequent quarterly reports. FAST-D

More News From Fastenal Company

Back to Newsroom

BEDFORD, NS / ACCESS Newswire / January 16, 2026 / (TSXV:SSE) - Silver Spruce Resources Inc. ("Silver Spruce" or the "Corporation") announces that the board of directors of the Corporation has approved the grant of an aggregate of 2,100,000 stock options to certain directors, officers, employees and consultants of the Corporation. Each option entitles the holder to acquire one common share of the Corporation at a price of $0.30 per share for a period of five years from the date of grant. The options were granted under and are subject to the terms and conditions of the Corporation's stock option plan.

About Silver Spruce Resources
Silver Spruce Resources Inc. is a Canadian junior exploration company. The Corporation's diversified exploration portfolio now includes:

Jackie Au-Ag Project - Early-stage epithermal project with high-grade surface sampling and strong structural targets located <10 kilometres northwest from Minera Alamos' Nicho deposit in eastern Sonora, Mexico

Pino de Plata Ag Project - High-grade silver property with historic artisanal mining located 15 kilometres west of Coeur Mining's Palmarejo Mine in western Chihuahua, Mexico

Melchett Lake VMS Zn-Ag-Au-Cu Project - Polymetallic project with historical drilling in the Thunder Bay Mining District of Ontario

Silver Spruce continues to investigate opportunities that Management has identified or that have been presented to the Corporation for consideration.

Contact:
Kevin O'Connor, Director
(312) 509-5972
[email protected]
www.silverspruceresources.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice Regarding Forward-Looking Statements

This news release contains "forward-looking statements". Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future..

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with mineral exploration and difficulties associated with obtaining financing on acceptable terms. We are not in control of metals prices and these could vary to make development uneconomic. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate.

SOURCE: Silver Spruce Resources, Inc.

Vancouver, B.C. — January 16, 2026 — TheNewswire - Nord Precious Metals Inc. (“Nord” or the "Company") (TSXV: NTH, OTCQB: CCWOF, FF: QN3) is pleased to announce that Heidi Gutte has been appointed as Chief Financial Officer of the Company effective January 15, 2026, replacing the Company’s CFO, Robert Suttie.

  Heidi Gutte has over 15 years of experience with publicly-traded mineral exploration and mining companies. She specializes in corporate finance, IFRS financial reporting, audit preparation and response, tax optimization, and corporate compliance for the mineral exploration and junior mining sector. Ms. Gutte holds a bachelor's degree in computer engineering from the University of Applied Sciences in Brandenburg, Germany. She is a Chartered Professional Accountant and a member of Chartered Professional Accountants of British Columbia and Canada.

  The Company thanks Mr. Suttie for his contributions to the Company and wishes him well in his future endeavors.

  About Nord Precious Metals Mining Inc.

Nord Precious Metals Mining Inc. operates TTL Laboratories, the only permitted high-grade milling facility in the historic Cobalt Camp of Ontario, where the Company has established an integrated position connecting high-grade silver discovery with strategic metals recovery operations.

The Company's flagship Castle property encompasses 63 sq. km of exploration ground and the past-producing Castle Mine, complemented by the Castle East discovery where drilling has delineated 7.56 million ounces of silver in Inferred resources grading an average of 8,582 g/t Ag (250.2 oz/ton) in 27,400 tonnes of material from two sections (1A and 1B) of the Castle East Robinson Zone, beginning at a vertical depth of approximately 400 metres. Mineral resources that are not mineral reserves do not have demonstrated economic viability. Please refer to the Nord Precious Metals Press Release of May 27, 2020, for the resource estimate.  The above resource is now considered an historical resource. Insufficient work has been done to categorize the above historical estimate as current. Significant additional diamond drilling and analytical work along with modelling is required before a new resource estimate can be compiled.

Nord's integrated processing strategy enables multiple metal recovery streams. High-grade silver recovery supports the economics of extracting critical minerals including cobalt, nickel, and other battery metals. The Re-2Ox hydrometallurgical process, validated at pilot scale through SGS Lakefield, eliminates the typical arsenic barriers in complex silver-cobalt ores while producing battery-grade cobalt sulphate and other metal products to customer specifications. This multi-metal approach, combined with established infrastructure including TTL Laboratories and underground mine access, positions Nord within Ontario's emerging critical minerals supply chain.

The Company maintains a strategic portfolio of battery metals properties in Northern Quebec including its 35% ownership in Coniagas Battery Metals Inc. (TSXV: COS), as well as the St. Denis-Sangster lithium project comprising 32 square kilometres of prospective ground near Cochrane, Ontario.

More information is available at www.nordpreciousmetals.com.

For further information please contact:

Frank J. Basa, P.Eng.

Chief Executive Officer

416-625-2342

or

Wayne Cheveldayoff

Corporate Communications

P: 416-710-2410

E: [email protected]

Forward-Looking Statements

This news release contains statements that constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results, performance or achievements, or developments in the industry to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements.

Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential" and similar expressions, or that events or conditions "will," "would," "may," "could" or "should" occur.

Forward-looking statements in this document include statements regarding: the expectation that the Company will receive Exchange approval for the Proposed Transaction; the potential for silver recovery from tailings; the Company's processing capabilities and integrated strategy; and the anticipated benefits of Ontario's regulatory and funding frameworks.

Although the Company believes the forward-looking information contained in this news release is reasonable based on information available on the date hereof, by their nature forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.

Examples of such assumptions, risks and uncertainties include, without limitation, assumptions, risks and uncertainties associated with: general economic conditions; adverse industry events; future legislative and regulatory developments; the Company's ability to access sufficient capital from internal and external sources; inability to access sufficient capital on favourable terms; the ability of the Company to implement its business strategies; competition; the ability of the Company to obtain and retain all applicable regulatory and other approvals; commodity price fluctuations; and other assumptions, risks and uncertainties.

THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS NEWS RELEASE REPRESENTS THE EXPECTATIONS OF THE COMPANY AS OF THE DATE OF THIS NEWS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE. READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER DATE. WHILE THE COMPANY MAY ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME EXCEPT AS REQUIRED IN ACCORDANCE WITH APPLICABLE LAWS.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

January 16, 2026 17:05 ET  | Source: Annexon Biosciences

BRISBANE, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that it has granted inducement to two new non-executive employees under the terms of the 2022 Employment Inducement Award Plan. The equity awards were approved on January 9, 2026, in accordance with Nasdaq Listing Rule 5635(c)(4).

In the aggregate, the new non-executive employees received options to purchase 155,000 shares of Annexon common stock. The options carry a ten-year term and an exercise price per share equal to $6.16, which was the closing price of Annexon’s common stock on January 15, 2026, the date of grant, and vest over 4 years, with 25% of the shares underlying the options vesting on the first anniversary of the grant date and an additional 1/48th of the shares vesting monthly thereafter, subject to continued service through the applicable vesting dates.

About Annexon

Annexon Biosciences (Nasdaq: ANNX) is advancing the next generation platform of targeted immunotherapies for nearly 10 million people worldwide living with serious neuroinflammatory diseases. Our founding scientific approach focuses on C1q, the initiating molecule of a potent inflammatory pathway that when misdirected can lead to tissue damage and loss of function in a host of diseases. Our targeted therapies are designed to stop classical complement-driven neuroinflammation at its source to provide meaningful functional benefit and alter the course of disease. Annexon’s mission is to deliver game-changing therapies to patients so that they can live their best lives. To learn more visit annexonbio.com.

Investor Contact:

Joyce Allaire
LifeSci Advisors
[email protected]

Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - The FUTR Corporation (TSXV: FTRC) (OTCQB: FTRCF) (FSE: QA20) (WKN: A4165Y) (ISIN: CA3609521057) ("FUTR" or the "Company"), creator of the FUTR Agent App which enables users to store, manage, access, and monetize their personal information and make real-time payments, today announced the appointment of G. Scott Paterson to its Board of Directors as Chairman of the Board, effective immediately.

"Scott brings exceptional public company experience to The FUTR Corporation with unparalleled capital markets expertise in the technology space, as well as a strong reputation in strategy, business development, financial management and governance," said Michael Hilmer, Vice Chairman of FUTR.

Mr. Paterson conceptualized FutureVault and led the conceptualization and incubation of FUTR as a division of FutureVault before it becoming publicly listed in the Spring of 2025. He recently disclosed an ownership position in excess of 10% of The FUTR Corporation, reflecting long-term alignment with the Company and its stakeholders. He previously served as Vice Chairman of the Toronto Stock Exchange (TSX) and Chairman of the TSX Venture Exchange.

He currently serves as Executive Chairman of FutureVault Inc., Chairman of QYOU Media Inc. (TSXV: QYOU). Mr. Paterson previously served for 21 years on the Board of Lionsgate Entertainment (NYSE: LION), including as Chair of its Audit & Risk Committee, and continues to serve within the Lionsgate universe as a Board member of Entertainment One Canada Ltd. Throughout his career, he has served on Boards of Directors of public companies listed on the NYSE, TSX, TSXV, AIM (UK) and CBOE exchanges.

"The monetization of consumer data has created trillion-dollar valuations for companies like Google and Meta," said Paterson. "While these platforms deliver significant value to their users, they do not share in the economics of that value creation. One of the core premises of the FUTR Agent App is that consumers should participate directly in the monetization of their personal information, and our App makes that possible."

The FUTR Agent App is built on two core premises: that consumers should participate directly in the monetization of their personal information, and that intelligent, agent-driven applications will become central to personal life management. The App enables users to securely upload documents, earn FUTR Tokens for their participation, and use intelligent document processing to surface answers, insights, and required actions from their documentation, including routine administrative tasks such as bill payments, saving users meaningful time.

Michael Hilmer will transition from Chairman of the Board to Vice Chairman of the FUTR Board of Directors and Vice Chairman of the Company. In this role, he will play a leadership role in enterprise and brand partnerships and M&A while continuing to support senior executive planning and strategy as the Company prepares to scale commercially in 2026. Mr. Hilmer brings more than 30 years of experience building and rapidly scaling companies, along with an extensive network expected to support FUTR's growth.

"2026 plans to be a blockbuster year for the Company as the FUTR Agent App will move from its current closed beta to its public launch. We will also see the continued maturation of the FUTR Token which is now live in the Agent App closed beta," Paterson added: "I would like to thank Michael Hilmer for his intensity, discipline and fundamental belief in The FUTR Corporations' vision and ability to execute at scale, as well as his leadership as Chairman and I look forward to continuing to work with him as Vice Chairman as the Company moves into its next phase of growth."

About The FUTR Corporation
The FUTR Agent App uses advanced AI and intelligent document processing to help consumers unlock the financial value of their personal information. By enabling users to monetize their data and instantly access key documents and insights, the App saves meaningful time and simplifies everyday financial tasks.
www.thefutrcorp.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/280700

Source: The FUTR Corporation

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

SAN DIEGO, Jan. 16, 2026 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that Smartsheet Inc. (NYSE: SMAR) shareholders who held Smartsheet securities as of the record date, October 25, 2024, and were harmed by defendants’ alleged violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 in connection with the acquisition of Smartsheet by Blackstone Inc., Vista Equity Partners Management, LLC, and the Abu Dhabi Investment Authority (“Merger”), have until February 24, 2026 to seek appointment as lead plaintiff of the Smartsheet class action lawsuit. The Smartsheet class action is captioned KaraEftimoglu v. Mader, No. 25-cv-02530 (W.D. Wash.).

If you held substantial Smartsheet securities as of the record date and wish to serve as lead plaintiff of the Smartsheet class action lawsuit, please provide your information here:

https://www.rgrdlaw.com/cases-smartsheet-inc-class-action-lawsuit-smar.html

You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected].

CASE ALLEGATIONS: Smartsheet is an enterprise software company providing software-as-a-service (“SaaS”) work management solutions. As a SaaS company, Smartsheet tracked its Annual Recurring Revenue (“ARR”) metric, which normalized contracted recurring revenue components of its subscription services to a one-year period.

The Smartsheet class action lawsuit alleges that in connection with Smartsheet’s solicitation of stockholder approval of the Merger, defendants issued and filed with the SEC a false and misleading Schedule 14A Proxy statement, as amended (“Proxy”). And as a direct result of the misleading Proxy, Smartsheet’s former shareholders approved the Merger and received the unfair price of $56.50 in cash for each share of Smartsheet common stock they owned, the complaint alleges.

Moreover, the Smartsheet class action lawsuit alleges among other things that every press release published and every associated earnings call during the period covered by the narrative in the Proxy touted Smartsheet’s increasing ARR metric, which management, after re-evaluating its business metrics, guided the market to rely on as the best indicator of Smartsheet’s future financial performance. Nevertheless, despite the clear materiality of this financial metric, the Proxy did not disclose this positive metric in the narrative, the complaint alleges. Nor did the Proxy disclose the January 2024 Forecasts prepared in the ordinary course of business – and not in the midst of negotiations – thereby preventing shareholders from comparing and fully assessing Smartsheet’s financial prospects, including any changes between the two sets of projections versus Smartsheet’s actual results and guidance, the Smartsheet shareholder class action alleges.

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who held Smartsheet securities as of the record date of the Merger to seek appointment as lead plaintiff in the Smartsheet class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Smartsheet investor class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Smartsheet shareholder class action lawsuit. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Smartsheet class action lawsuit.

ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world, and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:

https://www.rgrdlaw.com/services-litigation-securities-fraud.html

Past results do not guarantee future outcomes. 
Services may be performed by attorneys in any of our offices. 

Contact:
        Robbins Geller Rudman & Dowd LLP
        J.C. Sanchez
        655 W. Broadway, Suite 1900, San Diego, CA 92101
        800-449-4900
        [email protected]

Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - Vertiqal Studios Corp. (TSX: VRTS) (FSE: 9PY0) ("Vertiqal" or the "Company") Vertiqal, a leading digital-channel network and video-production studio, as well as the owner of North America's largest gaming and lifestyle network on social media, today announces that it has completed the sale of its Luminosity asset previously acquired from Enthusiast Gaming Holdings Inc. (see the Company's press release dated September 2, 2025).

The decision to divest Luminosity reflects Vertiqal's strategic focus on ensuring the long-term strength and sustainability of the brand. Vertiqal believes that Luminosity is best positioned to rebuild and thrive under dedicated ownership that can focus exclusively on its creators, vision, and community.

This transaction also reinforces Vertiqal's commitment to sharpening its focus on the core areas of the business that are driving meaningful momentum across the organization. With a portfolio anchored in social video channels, proprietary monetization infrastructure, and a best-in-class operational engine, Vertiqal is entering 2026 with a clear roadmap and an increasingly streamlined foundation. The Company will continue to re-allocate internal resources towards its most scalable revenue opportunities, accelerate innovation, strengthen strategic partnerships, and support the continued evolution of Vertiqal's network. The Company believes this focus will create a stronger, more resilient operating profile while positioning Vertiqal to capitalize on industry tailwinds and new market opportunities.

Following the transaction, Vertiqal will endeavour to remain engaged with Luminosity as a non-exclusive commercial partner on select sales efforts pursuant to a sales agency agreement executed between Vertiqal and Luminosity the "Sales Agency Agreement"). Beyond this partnership, the Luminosity business will be wholly sovereign from Vertiqal, operating independently with full control of its strategy and day-to-day management.

The purchase price paid by the buyer for the Luminosity asset was C$300,000 plus a C$125,000 payment payable to Vertiqal once revenue is collected in an amount of $125,000 pursuant to the Sales Agency Agreement. Vertiqal will retain all historical debts, liabilities, and unpaid creator obligations that arose prior to the change in ownership. The buyer did not acquire or assume these obligations and will focus exclusively on the future operation and rebuilding of the Luminosity brand.

Max Desmarais, President of Vertiqal Studios, commented: "Luminosity is a powerful legacy brand and has a passionate community behind it. We believe placing the brand in the hands of the new ownership is the right decision for its future. This transition enables Vertiqal to concentrate even further on our core growth engines, delivering on the strategy we have been building across our network and operational platforms. We remain aligned with Luminosity as a sales partner and look forward to seeing the brand thrive under its new owner."

About Vertiqal Studios Corp.

Vertiqal Studios is a scaled digital-channel network and video-production studio that owns North America's largest gaming and lifestyle network. The Company helps global brands reach Gen Z and Millennial audiences through data-driven creative, always-on digital campaigns, and performance-oriented distribution.

Vertiqal manages 200+ channels across TikTok, Instagram, YouTube, and Snapchat, producing over 100 pieces of content per day for a community of more than 52 million followers. Revenue is generated through a mix of direct brand partnerships, agency relationships, and platform monetization across its owned and operated channels.

Forward-Looking Information

This news release contains forward‐looking statements and forward‐looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward‐looking statements or information. The forward‐looking statements and information are based on certain key expectations and assumptions made by management of the Company. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward‐looking statements and information since no assurance can be given that they will prove to be correct.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward‐looking statements and information address future events and conditions, by their very nature, they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. Accordingly, readers should not place undue reliance on the forward‐looking statements and information contained in this news release.

The forward‐looking statements and information contained in this news release are made as of the date hereof, and no undertaking is given to update publicly or revise any forward‐looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/280690

Source: Vertiqal Studios

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

January 16, 2026 17:15 ET  | Source: Iovance Biotherapeutics, Inc.

SAN CARLOS, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that on January 15, 2026 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 97,710 shares of Iovance’s common stock to 17 new, non-executive employees.

The awards were granted under Iovance’s Amended and Restated 2021 Inducement Plan, which was adopted on September 22, 2021 and amended and restated on January 12, 2022, March 13, 2023, February 26, 2024, and November 22, 2024, and provides for the granting of equity awards to new employees of Iovance by the Company’s compensation committee in accordance with Nasdaq Listing Rule 5635(c)(4). Each of the stock options granted as referenced in this press release has an exercise price of $2.22, the closing price of Iovance’s common stock on the Date of Grant. Each stock option vests over a three-year period, with one-third of the shares vesting on the first anniversary of the employee’s start date (the “First Vesting Date”) and the remaining shares vesting in eight quarterly installments over the next two years, commencing with the first quarter following the First Vesting Date, subject to continued employment with the Company through the applicable vesting dates.

About Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc. aims to be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer. We are pioneering a transformational approach to cure cancer by harnessing the human immune system’s ability to recognize and destroy diverse cancer cells in each patient. The Iovance TIL platform has demonstrated promising clinical data across multiple solid tumors. Iovance’s Amtagvi® is the first FDA-approved T cell therapy for a solid tumor indication. We are committed to continuous innovation in cell therapy, including gene-edited cell therapy, that may extend and improve life for patients with cancer. For more information, please visit www.iovance.com.

Amtagvi® and its accompanying design marks, Proleukin®, Iovance®, and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks and registered trademarks are the property of their respective owners.

Forward-Looking Statements

Certain matters discussed in this press release are “forward-looking statements” of Iovance Biotherapeutics, Inc. (hereinafter referred to as the “Company,” “we,” “us,” or “our”) within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”). Without limiting the foregoing, we may, in some cases, use terms such as “predicts,” “believes,” “potential,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “forecast,” “guidance,” “outlook,” “may,” “can,” “could,” “might,” “will,” “should,” or other words that convey uncertainty of future events or outcomes and are intended to identify forward-looking statements. Forward-looking statements are based on assumptions and assessments made in light of management’s experience and perception of historical trends, current conditions, expected future developments, and other factors believed to be appropriate. Forward-looking statements in this press release are made as of the date of this press release, and we undertake no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, many of which are outside of our control, that may cause actual results, levels of activity, performance, achievements, and developments to be materially different from those expressed in or implied by these forward-looking statements. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in the sections titled "Risk Factors" in our filings with the U.S. Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.

CONTACTS

Investors
[email protected]
650-260-7120 ext. 150

Media
[email protected]
650-260-7120 ext. 150

Kitco News

The Leading News Source in Precious Metals

Kitco NEWS has a diverse team of journalists reporting on the economy, stock markets, commodities, cryptocurrencies, mining and metals with accuracy and objectivity. Our goal is to help people make informed market decisions through in-depth reporting, daily market roundups, interviews with prominent industry figures, comprehensive coverage (often exclusive) of important industry events and analyses of market-affecting developments.

New York, New York--(Newsfile Corp. - January 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Blue Owl Capital Inc. (NYSE: OWL) between February 6, 2025 and November 16, 2025, inclusive (the "Class Period"), of the important February 2, 2026 lead plaintiff deadline.

SO WHAT: If you purchased Blue Owl securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Blue Owl class action, go to https://rosenlegal.com/submit-form/?case_id=48876 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 2, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Blue Owl was experiencing a meaningful pressure on its asset base from business development companies ("BDC") redemptions; (2) as a result, Blue Owl was facing undisclosed liquidity issues; (3) as a result, Blue Owl would be likely to limit or halt redemptions of certain BDCs; and (4) accordingly, defendants had downplayed the true scope and severity of the negative impact as a result of the foregoing, defendants' positive statements about Blue Owl's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Blue Owl class action, go to https://rosenlegal.com/submit-form/?case_id=48876 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/280693

Source: The Rosen Law Firm PA

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

-

GLEN ALLEN, Va.--(BUSINESS WIRE)--Dynex Capital, Inc. (NYSE: DX) announced today that it will release its financial results for the fourth quarter and full year 2025 before market open and will host a conference call and live audio webcast to discuss its financial results at 10:00 a.m. ET on Monday, January 26, 2026.

Webcast Details

The live audio webcast will be accessible online at www.dynexcapital.com on the Investors page. An archive of the webcast will be available on the Company website approximately two hours after the live call ends.

Conference Call Details

Those wishing to listen to the live conference call via telephone should dial in at least 10 minutes before the call begins at (800) 330-6710 and provide the conference code 3915006.

For further information or questions, please contact Investor Relations at (804) 217-5897 or [email protected].

About Dynex Capital

Dynex Capital operates at the intersection of capital markets and the U.S. housing finance system, using our expertise to transform residential real estate into compelling long-term yields for our shareholders. We are committed to ethical stewardship of stakeholders' capital, expert risk management, disciplined capital allocation, and social responsibility. We generate dividend income and long-term total returns through the financing of real estate assets, and by doing so, support the growth and vitality of housing communities in the United States. Dynex Capital operates as a real estate investment trust (REIT) and is internally managed to maximize stakeholder alignment. Additional information is available at www.dynexcapital.com.

More News From Dynex Capital, Inc.

Back to Newsroom

, /PRNewswire/ -- Metallus (NYSE: MTUS), a leader in high-quality specialty metals, manufactured components, and supply chain solutions, and the United Steelworkers (USW) Local 1123 have reached a new tentative agreement for a four-year contract after members rejected previous agreements on October 30 and December 18, 2025. The date of the next vote will be set and announced by the union.

"We have reached a new tentative agreement that reflects our ongoing effort to balance both the needs of our employees and the priorities of the company," said Mike Williams, chief executive officer of Metallus. "The tentative contract offers a fair and reasonable resolution, and we value the constructive cooperation from all parties to reach a solution that benefits our employees, maintains job stability, and supports Metallus' future success."

To allow time for the union to communicate with its members and schedule the next vote, the current labor contract has been extended for an additional 14 days until February 12, 2026. Operations will continue as normal during this period.

The contract covers approximately 1,200 bargaining employees at the company's Canton, Ohio operations.

ABOUT METALLUS INC.
Metallus (NYSE: MTUS) manufactures high-performance specialty metals from recycled scrap metal in Canton, OH, serving demanding applications in industrial, automotive, aerospace & defense and energy end-markets. The company is a premier U.S. producer of alloy steel bars (up to 16 inches in diameter), seamless mechanical tubing and manufactured components. In the business of making high-quality steel for more than 100 years, Metallus' proven expertise contributes to the performance of our customers' products. The company employs approximately 1,850 people and had sales of $1.1 billion in 2024. For more information, please visit us at www.metallus.com. 

FORWARD-LOOKING STATEMENTS
This news release includes "forward-looking" statements within the meaning of the federal securities laws. You can generally identify the company's forward-looking statements by words such as "will," "anticipate," "aspire," "believe," "could," "estimate," "expect," "forecast," "outlook," "intend," "may," "plan," "possible," "potential," "predict," "project," "seek," "target," "should," "would," "strategy," or "strategic direction" or other similar words, phrases or expressions that convey the uncertainty of future events or outcomes. The company cautions readers that actual results may differ materially from those expressed or implied in forward-looking statements made by or on behalf of the company due to a variety of factors, such as: (1) the effects of fluctuations in customer demand on sales, product mix and prices in the industries in which the company operates, including the ability of the company to respond to rapid changes in customer demand including but not limited to changes in domestic and worldwide political and economic conditions due to, among other factors, U.S. and foreign trade policies and the impact on economic conditions, changes in customer operating schedules due to supply chain constraints or unplanned work stoppages, the ability of customers to obtain financing to purchase the company's products or equipment that contains its products, the effects of customer bankruptcies or liquidations, the impact of changes in industrial business cycles, and whether conditions of fair trade exist in U.S. markets; (2) changes in operating costs, including the effect of changes in the company's manufacturing processes, changes in costs associated with varying levels of operations and manufacturing capacity, availability of raw materials and energy, the company's ability to mitigate the impact of fluctuations in raw materials and energy costs and the effectiveness of its surcharge mechanism, changes in the expected costs associated with product warranty claims, changes resulting from inventory management, cost reduction initiatives and different levels of customer demands, the effects of unplanned work stoppages, availability of skilled labor and changes in the cost of labor and benefits; (3) the success of the company's operating plans, announced programs, initiatives and capital investments, the consistency to meet demand levels following unplanned downtime, and the company's ability to maintain appropriate relations with the union that represents its associates in certain locations in order to avoid disruptions of business; (4) whether the company is able to successfully implement actions designed to improve profitability on anticipated terms and timetables and whether the company is able to fully realize the expected benefits of such actions; (5) the company's pension obligations and investment performance; (6) with respect to the company's ability to achieve its sustainability goals, including its 2030 environmental goals, the ability to meet such goals within the expected timeframe, changes in laws, regulations, prevailing standards or public policy, the alignment of the scientific community on measurement and reporting approaches, the complexity of commodity supply chains and the evolution of and adoption of new technology, including traceability practices, tools and processes; (7) availability of property insurance coverage at commercially reasonable rates or insufficient insurance coverage to cover claims or damages; (8) the availability of financing and interest rates, which affect the company's cost of funds and/or ability to raise capital; (9) the impacts from any repurchases of our common shares, including the timing and amount of any repurchases; (10) competitive factors, including changes in market penetration, increasing price competition by existing or new foreign and domestic competitors, the introduction of new products by existing and new competitors, and new technology that may impact the way the company's products are sold or distributed; (11) deterioration in global economic conditions, or in economic conditions in any of the geographic regions in which the company conducts business, including additional adverse effects from global economic slowdown, terrorism or hostilities, including political risks associated with the potential instability of governments and legal systems in countries in which the company or its customers conduct business, and changes in currency valuations; (12) the impact of global conflicts on the economy, sourcing of raw materials, and commodity prices; (13) climate-related risks, including environmental and severe weather caused by climate changes, and legislative and regulatory initiatives addressing global climate change or other environmental concerns; (14) unanticipated litigation, claims or assessments, including claims or problems related to intellectual property, product liability or warranty, employment matters, regulatory compliance and environmental issues and taxes, among other matters; (15) cyber-related risks, including information technology system failures, interruptions and security breaches; (16) the potential impact of pandemics, epidemics, widespread illness or other health issues; and (17) with respect to the equipment investments to support the U.S. Army's mission of ramping up munitions production in the coming years, whether the funding awarded to support these investments is received on the anticipated timetable, whether the company is able to successfully complete the installation and commissioning of the new assets on the targeted budget and timetable, and whether the anticipated increase in throughput is achieved. Further, this news release represents our current policy and intent and is not intended to create legal rights or obligations. Certain standards of measurement and performance contained in this news release are developing and based on assumptions, and no assurance can be given that any plan, objective, initiative, projection, goal, mission, commitment, expectation or prospect set forth in this news release can or will be achieved. Inclusion of information in this news release is not an indication that the subject or information is material to our business or operating results.

Additional risks relating to the company's business, the industries in which the company operates, or the company's common shares may be described from time to time in the company's filings with the SEC. All of these risk factors are difficult to predict, are subject to material uncertainties that may affect actual results and may be beyond the company's control. Readers are cautioned that it is not possible to predict or identify all of the risks, uncertainties and other factors that may affect future results and that the above list should not be considered to be a complete list. Except as required by the federal securities laws, the company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

SOURCE Metallus Inc.

, /PRNewswire/ - A2Z Cust2Mate Solutions Corp. (the "Company") (NASDAQ: AZ), a global leader in smart retail technology, today announces that on January 13, 2026 the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market ("Nasdaq") stating that, since the Company has not yet held an annual meeting of shareholders within twelve months of the Company's fiscal year end, the Company is no longer in compliance with Nasdaq Listing Rules 5620(a) and 5810(c)(2)(G).

The Company expects to consult with Nasdaq regarding whether holding the annual meeting, currently anticipated for March 31, 2026, will restore compliance with the Nasdaq Listing Rule 5620(a) and 5810(c)(2)(G) or whether Nasdaq will require any additional action. There can be no assurance that Nasdaq will accept the Company's compliance plan or that the Company will regain compliance within any exception period that may be granted. The Company has 45 calendar days to submit a plan to regain compliance. If Nasdaq does accept the Company's proposed plan and meeting date, then Nasdaq may grant an exception of up to 180 calendar days from the fiscal year end, or until June 29, 2026, to regain compliance.

The Nasdaq letter has no immediate effect on the listing or trading of the Company's securities on the Nasdaq stock market.

About A2Z Cust2Mate Solutions Corp.

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) creates innovative solutions for complex challenges that bring innovation, ease, excitement and value to retailers and shoppers. The company's flagship innovative smart cart solutions are transforming brick-and-mortar retail, bridging online and in-store shopping through interactive technology that guides and informs customers. Cust2Mate's AI-driven smart carts personalize every in-store journey, turning routine trips into engaging, rewarding experiences. They enable seamless in-cart scanning and payment, allowing shoppers to bypass checkout lines while receiving real-time customized offers and product recommendations. This enhanced customer experience boosts satisfaction and loyalty while helping retailers streamline operations and optimize merchandising through data-driven insights. The carts are equipped with multiple layers of security for accurate recognition and transaction integrity. Its modular, all-in-one detachable panels transform legacy shopping cart fleets into intelligent platforms that deliver a range of benefits.

For more information on A2Z Cust2Mate Solutions Corp. and its subsidiary, Cust2Mate Ltd., please visit: www.cust2mate.com.

Forward Looking Statements

Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "will", "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, statements regarding the Company's intent to submit a compliance plan to Nasdaq, the timing of an annual meeting of shareholders, and the Company's expectations regarding regaining compliance with Nasdaq's listing rules., and other matters detailed in reports filed by the Company with the Securities and Exchange Commission.

SOURCE A2Z Cust2Mate Solutions Corp.